Hmmm ... that does change my price target, i'll set it at above $3.5 a share now.Very strong momentum.Let's see good revenue in the quarterly and we'll start a new ascending channel towards the $1.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025